AHAliuska Morales Helguera

Aliuska Morales Helguera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aliuska Morales Helguera has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biopolymer Fibers of High Strength and Enhanced Orientation by the Synergy of High/Low Molecular Weight Chitosans in Hybrid Biomaterials Processed by Gel Spinning

    by Tuan Anh Tran, Ingo Doench, Arnaud Kamdem Tamo, Shaghayegh Jahangir, Sofia Marquez-Bravo, Pamela Molina, Martin Helmstaedter, Aliuska Morales Helguera, Christian Gorzelanny, Anayancy Osorio-Madrazo

    High-performance spun bionanocomposite fibers, composed of high-molecular-weight chitosan (HMW), low-molecular-weight chitosan “oligomers” (LMW), and cellulose nanofibers (CNFs), were successfully fabricated via gel spinning of viscous aqueous chitosan (CHI) based formulations into a NaOH coagulation bath. The X-ray diffraction (XRD) analysis revealed that the incorporation of cellulose nanofibers contributed to enhance crystallinity of chitosan in spun fibers. The spinning process, which comprised sequential acidic solubilization, basic neutralization, stretching, and drying steps, produced chitosan/CNF composite fibers with high crystallinity, further enhanced by the incorporation of low molecular weight chitosan. The cellulose nanofibers seem to promote CHI crystallization, by acting as nucleation sites for the nucleation and growth of chitosan crystals, with those latter of LMW further enhancing crystallization and orientation due to higher mobility of shorter polymer chains. Two-dimensional XRD patterns demonstrated the preferential alignment of both CNFs and chitosan crystals along the fiber axis. Increasing the proportion of short-chain chitosan led to a reduction of the viscosity of collodion, facilitating the spinning of solutions with higher polymer concentrations. The X-ray diffraction (XRD) analysis revealed that the addition of low-molecular-weight chitosan (LMW), with an intermediate molecular weight Mw of ~4.4 × 104 g/mol, produced the most significant improvements in the crystallinity index (CrI) and orientation. This structural enhancement corresponded to superior mechanical properties like Young’s modulus, yield stress σy, and stress-at-break σb of the processed composite fibers. By incorporating that intermediate molecular weight chitosan, a Young’s modulus as high as 20 GPa was achieved for the spun composite fibers, which was twice higher than the modulus of around 10 GPa obtained by adding the lowest molecular weight chitosan of Mw ~ 2.9 × 104 g/mol in the composite, and largely above the modulus of around 5 GPa obtained for fiber just spun with chitosan without incorporation of cellulose nanofibers.


  • Open Access

    Computational Investigation of the Potential Antileishmanial Mechanism of the Nitroindazole Derivative VATR131

    by Omar Casanova-Alvarez, Niurka Mollineda-Diogo, Aliuska Morales-Helguera, Vicente Arán-Redó, Reinaldo Molina-Ruiz, Norberto Sánchez-Cruz, Yendrek Velásquez-López, Yunierkis Perez-Castillo

    Background: Neglected tropical diseases (NTDs) significantly impact global health, particularly affecting impoverished communities. Among these diseases, leishmaniasis, caused by protozoan parasites of the genus Leishmania and transmitted through sandfly vectors, remains a challenge due to limited therapeutic options. Current treatments often suffer from significant limitations, such as high toxicity, limited efficacy, and the emergence of drug resistance. Objectives: This study investigates the potential antileishmanial mechanism of action of nitroindazole derivatives, specifically evaluating the compound VATR131, a molecule with notable selectivity and potency against Leishmania infantum. Methods: We employed computational methodologies, including target fishing, molecular docking, and atomistic molecular dynamics simulations, to identify and characterize potential molecular targets of VATR131. Results: The analysis revealed cysteine peptidase A as a promising target potentially mediating the antileishmanial activity of VATR131. Molecular dynamics simulations suggest critical hydrophobic interactions and hydrogen bonds between the compound and its most likely receptor, thus offering deeper insights into its potential mechanism of action. Conclusions: These findings contribute to the development of novel and effective therapies for leishmaniasis, highlighting the need for experimental validation and continued investigation of nitroindazole derivatives as promising therapeutic candidates.

  • Open Access

    Biopolymer Fibers of High Strength and Enhanced Orientation by the Synergy of High/Low Molecular Weight Chitosans in Hybrid Biomaterials Processed by Gel Spinning

    by Tuan Anh Tran, Ingo Doench, Arnaud Kamdem Tamo, Sofia Marquez-Bravo, Pamela Molina, Martin Helmstaedter, Aliuska Morales Helguera, Christian Gorzelanny, Anayancy Osorio-Madrazo

    High-performance spun bionanocomposite fibers composed of high-molecular-weight chitosan (CHI), low-molecular-weight chitosan "oligomers", and cellulose nanofibers (CNFs) were successfully fabricated via gel spinning of viscous aqueous CHI formulations into a NaOH coagulation bath. X-ray diffraction (XRD) analysis revealed that the CHI polymer chains crystallized into the anhydrous chitosan allomorph. The spinning process which comprised of sequential acidic, basic, neutralization, stretching, and drying steps, produced CHI/CNF composite fibers with high crystallinity, further enhanced by the incorporation of chitosan oligomers. These oligomers appear to promote CHI crystallization by acting as nucleation sites for crystal growth. Two-dimensional XRD patterns demonstrated preferential alignment of both CNFs and CHI crystals along the fiber axis. Increasing the proportion of short-chain chitosan reduced the dope viscosity, potentially facilitating the spinning of solutions with higher polymer concentrations. XRD results indicated that the addition of low-molecular-weight chitosan with an intermediate molecular weight of approximately 4.4 × 10⁴ g/mol produced the greatest increase in crystallinity index (CrI) and molecular orientation, leading to optimal mechanical performance.

  • Validation of venous thromboembolism predictive model in hematologic malignancies

    by Agnerys López Sacerio, Mara Caridad Tejeda Ramón, Aliuska Morales Helguera, Yunierkis Pérez Castillo, Javier Cruz Rodríguez, Jorge Felix Guerra Rodríguez, Anna Falanga

    Although several scores stratify venous thromboembolism (VTE) risk in solid tumors, hematologic malignancies (HM) are underrepresented. To develop an internal and external validation of a logistic regression model to predict VTE risk in hospitalized HM patients. Validation of the existing VTE predictive model was performed through a prospective case–control study in 496 hospitalized HM patients between December 2010 and 2020 at the Arnaldo Milián University Hospital, Cuba. The predictive model designed with data from 285 patients includes 5 predictive factors: hypercholesterolemia, tumoral activity, use of thrombogenic drugs, diabetes mellitus, and immobilization. The model was internally validated using bootstrap analysis. External validation was realized in a prospective cohort of 211 HM patients. The predictive model had a 76.4% negative predictive value (NPV) and an 81.7% positive predictive value (PPV) in the bootstrapping validation. The area under curve (AUC) in the bootstrapping set was 0.838. Accuracy was 80.1% and 82.9% in the internal and external validation, respectively. In the external validation, the model produced 89.7% of NPV, 67.7% of PPV, 74.6% of sensitivity, and 86.2% of specificity. The AUC in the external validation was 0.900. VTE predictive model is a reproducible and simple tool with good accuracy and discrimination.


  • Open Access

    Virtual screening tailored ensembles of QSAR models for the discovery of dual A2A Adenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors

    by Fernanda Borges, Maykel Cruz-Monteagudo, Aliuska Morales-Helguera, Yunierkis Pérez-Castillo, M. Natália D. S. Cordeiro, Eduardo Tejera, Cesar Paz-Y-Miño, Aminael Sánchez-Rodríguez, Marta Teijeira-Bautista, Evys Ancede-Gallardo, et al.

    Virtual Screening methodologies have emerged as efficient alternatives for the discovery of new drug candidates. At the same time, ensemble methods are nowadays frequently used to overcome the limitations of employing a single model in ligand-based drug design. However, many applications of ensemble methods to this area do not consider important aspects related to both virtual screening and the modeling process. During the application of ensemble methods to virtual screening the proper validation of the models in virtual screening conditions is often neglected. Frequently no analysis is performed of the diversity of the ensemble members or no considerations regarding the applicability domain of the base model are made. In this research we propose a method employing genetic algorithms optimization for the generation of virtual screening tailored ensembles that address problems in the current applications of ensemble methods to virtual screening. The proposed methodology is successfully applied to the generation of ensemble models for the ligand-based virtual screening of dual target A2A adenosine receptor antagonists and MAO-B inhibitors as potential Parkinson’s disease therapeutics.

  • Open Access

    Improved virtual screening performance through docking scoring fusion in the discovery of dual target ligands for Parkinson’s disease

    by Yunierkis Pérez-Castillo, Aliuska Morales-Helguera, M. Natália D. S. Cordeiro, Eduardo Tejera, Cesar Paz-Y-Miño, Aminael Sánchez-Rodríguez, Fernanda Borges, Maykel Cruz-Monteagudo

    Virtual methodologies have become essential components of the drug discovery pipeline. Specifically, structure-based drug design methodologies exploit the 3D structure of molecular targets to discover new drug candidates through molecular docking. Recently, dual target ligands of the Adenosine A2A Receptor and Monoamine Oxidase B enzyme have been proposed as effective therapies for the treatment of Parkinson’s disease. To the best of our knowledge, no theoretical study has been devoted to developing structure-based virtual screening methodologies for the discovery of dual A2AAR antagonists and MAO-B inhibitors. In this communication we propose a structure-based methodology for the discovery this type of molecules

  • Classifier Ensemble Based on Feature Selection and Diversity Measures for Predicting the Affinity of A2BAdenosine Receptor Antagonists

    by Isis Bonet, Pedro Franco-Montero, Virginia Rivero, Marta Teijeira, Fernanda Borges, Eugenio Uriarte, Aliuska Morales Helguera

    A2B adenosine receptor antagonists may be beneficial in treating diseases like asthma, diabetes, diabetic retinopathy, and certain cancers. This has stimulated research for the development of potent ligands for this subtype, based on quantitative structure-affinity relationships. In this work, a new ensemble machine learning algorithm is proposed for classification and prediction of the ligand-binding affinity of A2B adenosine receptor antagonists. This algorithm is based on the training of different classifier models with multiple training sets (composed of the same compounds but represented by diverse features). The k-nearest neighbor, decision trees, neural networks, and support vector machines were used as single classifiers. To select the base classifiers for combining into the ensemble, several diversity measures were employed. The final multiclassifier prediction results were computed from the output obtained by using a combination of selected base classifiers output, by utilizing different mathematical functions including the following: majority vote, maximum and average probability. In this work, 10-fold cross- and external validation were used. The strategy led to the following results: i) the single classifiers, together with previous features selections, resulted in good overall accuracy, ii) a comparison between single classifiers, and their combinations in the multiclassifier model, showed that using our ensemble gave a better performance than the single classifier model, and iii) our multiclassifier model performed better than the most widely used multiclassifier models in the literature. The results and statistical analysis demonstrated the supremacy of our multiclassifier approach for predicting the affinity of A2B adenosine receptor antagonists, and it can be used to develop other QSAR models.


  • Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors

    by Aliuska Morales Helguera, Alfonso Pérez-Garrido, Alexandra Gaspar, Joana Reis, Fernando Cagide, Dolores Vina, M.NAtália D.S. Cordeiro, Fernanda Borges


  • Discovery of MAO-B Inhibitors - Present Status and Future Directions Part I: Oxygen Heterocycles and Analogs

    by A. M. Helguera, G. Perez-Machado, M. N. D.S. Cordeiro, F. Borges

    Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The role of monoamine oxidase (MAO) inhibitors has expanded in the PD treatment. The present review will summarize the current structureactivity relationship information available on MAOs inhibitors of unrelated families of compounds of oxygen heterocyclic type based on coumarin, chromone and chalcone scaffolds. As the current hitting-one-target therapeutic strategy has been proved to be quite inefficient in PD, this review will also discuss about the development of multi-target drugs, in which MAO inhibition plays a counter-part, as a novel and promising treatment approach for PD.


  • Topological sub-structural molecular design approach: Radical scavenging activity

    by Alfonso Pérez-Garrido, Aliuska Morales Helguera, Juana M. Morillas Ruiz, Pilar Zafrilla Rentero